Antigenics, Inc. (NASDAQ:AGEN)

CAPS Rating: 2 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

Recs

0
Player Avatar Dart65GTConv (< 20) Submitted: 6/24/2008 9:45:00 AM : Outperform Start Price: $10.62 AGEN Score: -56.20

u[p

Report this Post Reply

Featured Broker Partners


Advertisement